These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 580038)

  • 21. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
    Werner H; Heizmann W; Luft G
    Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythromycin and anaerobes: in vitro aspects.
    Watt B
    Scott Med J; 1977 Dec; 22(5):389-91. PubMed ID: 341310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on in vitro susceptibility of various anaerobic bacteria and antimicrobial resistance of anaerobes (author's transl)].
    Okada J
    Jpn J Antibiot; 1982 Feb; 35(2):325-61. PubMed ID: 6979640
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro sensitivity of anaerobic bacteria to fosfomycin.
    Altés Gutiérrez A; Rodríguez Noriega A
    Chemotherapy; 1977; 23 Suppl 1():51-7. PubMed ID: 583867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
    Dubreuil L; Devos J; Beerens H; Romond C
    Pathol Biol (Paris); 1988 May; 36(5):488-92. PubMed ID: 3043345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.
    Sutter VL; Finegold SM
    J Infect Dis; 1975 Apr; 131(4):417-22. PubMed ID: 804023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial activity of antituberculosis agents against anaerobic bacteria.
    Thadepalli H; Bach VT; Webb DW
    Chest; 1979 May; 75(5):569-70. PubMed ID: 436485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.
    Robbins MJ; Marais R; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1987; 13(9):551-4. PubMed ID: 2962846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria.
    Felmingham D; Robbins MJ; Marais R; Ridgway GL; Gruneberg RN
    Drugs Exp Clin Res; 1987; 13(4):195-9. PubMed ID: 3113907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
    Schumacher U; Manncke B; Gerbracht K; Werner H
    Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is ciprofloxacin active against clinically important anaerobes?
    Watt B; Brown FV
    J Antimicrob Chemother; 1986 May; 17(5):605-13. PubMed ID: 2941400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Fusobacteria in Antibacterial agents.
    Niederau W; Höffler U; Pulverer G
    Arzneimittelforschung; 1980; 30(12):2093-8. PubMed ID: 7194067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of New Zealand isolates to anaerobic bacteria to tinidazole.
    Tannock GW
    N Z Med J; 1979 Aug; 90(642):149-50. PubMed ID: 290923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Susceptibility to tetracycline and doxycycline of 80 strains of Bacteroides fragilis, B, thetaiotaomicron, and B. vulgatus mostly isolated in 1973/74 (author's transl)].
    Spengruber B; Werner H
    Zentralbl Bakteriol Orig A; 1975 May; 231(4):471-84. PubMed ID: 1179870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.
    Jacobus NV; Tally FP; Barza M; Gorbach SL
    Clin Ther; 1980; 3(Spec Issue):34-8. PubMed ID: 6446396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
    Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.